Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Femoral Fractures D005264 7 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Acidosis D000138 13 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Ulcer D014456 16 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Proteinuria D011507 30 associated lipids
Arteriosclerosis D001161 86 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fetal Diseases D005315 8 associated lipids
Glomerulonephritis D005921 35 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Sepsis D018805 11 associated lipids
Leukopenia D007970 9 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Seizures D012640 87 associated lipids
Peptic Ulcer D010437 19 associated lipids
Birth Weight D001724 23 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Thromboembolism D013923 6 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Nanji AA et al. Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. 1997 Gastroenterology pmid:8978360
Mathieu P et al. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study]. 1996 Pathol. Biol. pmid:8977914
Sergeev PV et al. [Human thrombocytes as a test system for the study of nongenomic effects of glucocorticoid hormones]. 1996 Biull Eksp Biol Med pmid:8974481
Landoni MF and Lees P Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. 1996 J. Vet. Pharmacol. Ther. pmid:8971676
Li KL et al. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. 1996 J. Periodont. Res. pmid:8971650
Fukushima C et al. Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma. 1996 Ann. Allergy Asthma Immunol. pmid:8970439
Hirakata H et al. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. 1996 Anesthesiology pmid:8968193
Reilly M et al. Modulation of oxidant stress in vivo in chronic cigarette smokers. 1996 Circulation pmid:8964113
Gries A et al. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. 1996 Arterioscler. Thromb. Vasc. Biol. pmid:8963722
Serebruany VL et al. Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swine. 1996 J. Cardiovasc. Pharmacol. pmid:8961080
Milani M et al. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. 1996 Biomed. Pharmacother. pmid:8952866
Baenkler HW et al. Eicosanoids from biopsy of normal and polypous nasal mucosa. 1996 Rhinology pmid:8938887
Krämer HJ et al. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. 1996 Biochem. Pharmacol. pmid:8937428
Klosterhalfen B et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. 1996 Biochem. Pharmacol. pmid:8937427
Janssen PL et al. Consumption of ginger (Zingiber officinale roscoe) does not affect ex vivo platelet thromboxane production in humans. 1996 Eur J Clin Nutr pmid:8933126
Cirino G et al. Indomethacin and thromboxane A2/prostaglandin H2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats. 1996 J Lipid Mediat Cell Signal pmid:8925198
Blache D Enhanced arachidonic acid and calcium metabolism in cholesteryl sulfate-enriched rat platelets. 1996 J Lipid Mediat Cell Signal pmid:8925194
Shibasaki T et al. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. 1996 Am. J. Nephrol. pmid:8919236
Okada M et al. Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent. 1996 Immunology pmid:8911154
Ferrándiz ML et al. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. 1996 J. Pharm. Pharmacol. pmid:8910867
Szekacs B et al. Prostacyclin and thromboxane production of rat and cat arterial tissue is altered independently by several vasoactive substances. 1996 Prostaglandins pmid:8908622
Chello M et al. Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease. 1996 J. Cardiovasc. Pharmacol. pmid:8907804
Schmid P et al. Passive smoking and platelet thromboxane. 1996 Thromb. Res. pmid:8907294
Berdeaux O et al. Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. 1996 J. Lipid Res. pmid:8906600
Nishisho T et al. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. 1996 Neurosurgery pmid:8905750
Montuschi P et al. Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. 1996 Eur. J. Pharmacol. pmid:8905345
Martin W et al. Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. 1996 Eur J Cardiothorac Surg pmid:8905281
Parnas BL et al. Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus. 1996 J. Nat. Prod. pmid:8904845
Serebruany VL et al. Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. 1996 Pharmacology pmid:8902873
Livingston ER et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. 1996 Circulation pmid:8901751
Karck U et al. PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. 1996 Prostaglandins pmid:8900443
Harada Y et al. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. 1996 Prostaglandins pmid:8900441
Chou TC et al. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation. 1996 Thromb. Res. pmid:8897698
Myers SI et al. Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8888351
Stiris TA et al. Effects of dexamethasone on retinal and choroidal blood flow during normoxia and hyperoxia in newborn piglets. 1996 Pediatr. Res. pmid:8888288
Carbajal D et al. Possible cytoprotective mechanism in rats of D-002, an anti-ulcerogenic product isolated from beeswax. 1996 J. Pharm. Pharmacol. pmid:8887738
García-Lafuente A et al. Bacterial peptides enhance inflammatory activity in a rat model of colitis. 1996 Digestion pmid:8886582
Ziyyat A et al. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. 1996 Br. J. Pharmacol. pmid:8886425
Selley ML et al. The effect of cholesterol oxidation products on human platelet aggregation. 1996 Thromb. Res. pmid:8885139
Mustad V et al. Seasonal variation in parameters related to coronary heart disease risk in young men. 1996 Atherosclerosis pmid:8879440
Schaefer WR et al. Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. 1996 Prostaglandins pmid:8875634
Siler-Khodr TM et al. Dose-related action of estradiol on placental prostanoid prediction. 1996 Prostaglandins pmid:8873234
Kanai H et al. Serotonin metabolism in patients undergoing hemodialysis. 1996 Clin. Nephrol. pmid:8861800
Pancera P et al. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8860111
Bordia T et al. An evaluation of garlic and onion as antithrombotic agents. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8860105
Reale M et al. Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist. 1996 Mol. Cell. Biochem. pmid:8858567
Quinn JV et al. Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. 1996 Shock pmid:8856849
Chen SJ et al. Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. 1996 Gen. Pharmacol. pmid:8853295
Gabriel A et al. Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta. 1996 J. Cardiothorac. Vasc. Anesth. pmid:8850397
Horiguchi T et al. Pulmonary responses to heparin-protamine complexes: the effects of age and species. 1996 J. Appl. Physiol. pmid:8847332